IMMUNETICS, INC. — Form D
IMMUNETICS, INC. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-10. The offering totals $3.0M, of which $835K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-03-10
- Form: D
- Accession: 0001056227-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $835K
- Remaining: $2.2M
- Minimum investment: $25K
- Investors: 12
- Date of first sale: 2014-02-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-213271
Issuer
- Name: IMMUNETICS, INC.
- CIK: 0001056227
- Entity type: Corporation
- Jurisdiction: MASSACHUSETTS
- Address: 27 DRYDOCK AVE., BOSTON, MA, 02210
- Phone: (617) 896-9100
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Stephen Chubb | Director | BOSTON, MA |
| Richard Gibbs | Director | BOSTON, MA |
| Andrew Levin | Director | BOSTON, MA |
| Lois Silverman | Director | BOSTON, MA |
| John Yonkin | Director | Boston, MA |
| Ron Zwanziger | Director | BOSTON, MA |
| Andrew Levin | Executive Officer | BOSTON, MA |
| Richard Pinkowitz | Executive Officer | BOSTON, MA |
| John Yonkin | Executive Officer | Boston, MA |
| Houry Youssoufian | Executive Officer | BOSTON, MA |
Other filings by this issuer (1)
More